Desq Long
Sign in
SEC FORM 4
$143,550.00

Rapport Therapeutics, Inc. (RAPP)

Purchase of 5,500 shares at $26.10 per share.

Reporting Person Ignelzi Troy A. · Officer Title Chief Financial Officer · Transaction Code P

Traded Oct 21, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001193125-26-428018 · filed 2026-10-21 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Rapport Therapeutics, Inc. (RAPP)." Disclosed 2026-10-21. https://desqlong.com/cards/0001193125-26-428018-1 (retrieved 2026-10-22).